{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:41:31Z","timestamp":1770298891121,"version":"3.49.0"},"reference-count":14,"publisher":"FapUNIFESP (SciELO)","issue":"2A","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[1999,6]]},"abstract":"<jats:p>Subacute sclerosing panencephalitis (SSPE) is an inflammatory neurodegenerative disease related to the persistence of measles virus. Although its frequency is declining because of measles eradication, we still have some cases being diagnosed. With the aim to describe epidemiological aspects of SSPE in Brazil, we sent a protocol to Child Neurologists around the country, 48 patients were registered, 27 (56 %) were from the southeast region, 34 (71%) were male and 35 (73%) white, 27 (56%) had measles, 9 (19%) had measles and were also immunized, 7 (14%) received only immunization, 1 patient had a probable neonatal form. Mean time between first symptoms and diagnosis was 12 months (22 started with myoclonus or tonic-clonic seizures, 7 (14%) with behavioral disturbances); 36 patients (75%) had EEG with pseudoperiodic complexes. Follow up performed in 28 (58 %) patients showed: 12 died, 2 had complete remission and the others had variable neurological disability Our data shows endemic regions in the country, a high incidence of post-immunization SSPE and a delay between first symptom and diagnosis.<\/jats:p>","DOI":"10.1590\/s0004-282x1999000200002","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T10:24:16Z","timestamp":1113560656000},"page":"176-181","source":"Crossref","is-referenced-by-count":11,"title":["Subacute sclerosing panencephalitis: clinical aspects and prognosis. The Brazilian Registry"],"prefix":"10.1590","volume":"57","author":[{"given":"MAGDA LAHORGUE","family":"NUNES","sequence":"first","affiliation":[{"name":"PUCRS"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JADERSON COSTA DA","family":"COSTA","sequence":"additional","affiliation":[{"name":"PUCRS"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VANESSA M.","family":"STANCHER","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ARON","family":"DIAMENT","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FERNANDO","family":"ARITA","sequence":"additional","affiliation":[{"name":"Santa Casa de S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00c9RGIO","family":"ROSEMBERG","sequence":"additional","affiliation":[{"name":"Santa Casa de S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PAUL","family":"DYKEN","sequence":"additional","affiliation":[{"name":"IRCND, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0733-8619(18)31062-4","article-title":"Subacute sclerosing panencephalitis: current status","volume":"3","author":"Dyken P","year":"1985","journal-title":"Neurol Clin","ISSN":"https:\/\/id.crossref.org\/issn\/0733-8619","issn-type":"print"},{"key":"ref2","series-title":"Child neurology","first-page":"859","volume-title":"Subacute sclerosing panencephalitis","author":"Dyken P","year":"1996"},{"key":"ref3","series-title":"International multicenter treatment study of inosiplex and alpha interferon in subacute sclerosing panencephalits","author":"Gascon GG","year":"1996"},{"key":"ref4","series-title":"Boletim Epidemiol\u00f3gico (measles notification)","year":"1996"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0887-8994(95)00145-6","article-title":"Trihexyphenidyl and isoprinosine in the treatment of subacute sclerosing panencephalitis","volume":"13","author":"Nunes ML","year":"1995","journal-title":"Pediatr Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0887-8994","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1212\/WNL.37.12.1883","article-title":"From the national SSPE registry","volume":"37","author":"Dyken P","year":"1987","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0887-8994(89)90045-3","article-title":"Changing character of Subacute sclerosing panencephalitis in the United States","volume":"5","author":"Dyken P","year":"1989","journal-title":"Pediatric Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0887-8994","issn-type":"print"},{"key":"ref8","first-page":"17","article-title":"Panencefalite esclerosante subaguda associada \u00e0 gesta\u00e7\u00e3o (SSPE associated with pregnancy)","volume":"4","author":"Da Costa JC","year":"1991","journal-title":"J Liga Bras Epilepsia (JLBE)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0022-3476(79)80829-X","article-title":"Epidemiology of subacute sclerosing panencephalitis","volume":"94","author":"Modlin JF","year":"1979","journal-title":"Pediatrics","ISSN":"https:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1590\/S0004-282X1967000400002","article-title":"Subacute sclerosing leukoencephalitis: an epidemiological, clinical and biochemical study of 31 cases","volume":"25","author":"Canelas HM","year":"1967","journal-title":"Arq Neuropsiquiatr","ISSN":"https:\/\/id.crossref.org\/issn\/0004-282X","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ije\/18.3.684","article-title":"Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan","volume":"18","author":"Okuno Y","year":"1989","journal-title":"Internati J Epidemiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/106002808401800503","article-title":"Treatment of subacute sclerosing panencephalitis: an overview","volume":"18","author":"Taylor WJ","year":"1984","journal-title":"Drug Intell Clin Pharm","ISSN":"https:\/\/id.crossref.org\/issn\/0012-6578","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1212\/WNL.42.3.488","article-title":"Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis","volume":"42","author":"Yalaz K","year":"1992","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.47.6.1604","article-title":"Healthy infant delivered by a mother with subacute sclerosing panencephalitis during pregnancy","volume":"47","author":"Thiel A","year":"1996","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v57n2a\/1465.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T11:28:37Z","timestamp":1550057317000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X1999000200002&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":14,"journal-issue":{"issue":"2A","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["S0004-282X1999000200002"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x1999000200002","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}